New cancer clinical trial: Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer

Published on: November 01, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share